PharmaBoardroom

Standing on the Shoulders of Giants: The Art & Science of…

DataArt's Daniel Piekarz looks at how machine learning and artificial intelligence can play into the important task of drug repurposing, potentially…

Latin America Pharma News Roundup May 2020

Below we highlight recent news in the Latin America region, focusing on Argentina, Colombia and Chile. Top stories cover the fight against COVID-19,…

The UAE: A Gathering Force

Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most…

Johnsee Lee – Chairman, Taiwan Bio Industry Organization;…

Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s rapid and coordinated response to the…

Sylvie Rottey – President, Belgian Society of Medical…

Professor Sylvie Rottey, president of the Belgian Society of Medical Oncology (BSMO) outlines the state of cancer care in Belgium, the country’s…

Driss Chaoui – CEO, Afric-Phar, Morocco

Dr Driss Chaoui, CEO of Afric-Phar, one of the leading domestic companies in Moroccan pharma, provides insight into the major developments that have…

Karim Lahlou – General Manager, Iberma, Morocco

Karim Lahlou of Moroccan pharma manufacturer Iberma discusses the firm's evolution in recent years, the abundant opportunities for Iberma in the…

Aldo Donati – CEO, IBSA USA

Aldo Donati, CEO for Swiss firm IBSA in the USA, discusses the challenges for European mid-caps in expanding to the US market and his portfolio…

Worried About Biogen’s Aducanumab? Don’t Be

Dr Neil Cashman examines the recent news around Biogen's Alzheimer's treatment aducanumab, assuages some investor fears, and underlines the…

China Pharma News Roundup May 4th 2020

A selection of recent big stories from Chinese pharma, including Novo Nordisk's updated China strategy, Chinese biotechs' funding successes, and some…

Hot Topics in US Healthcare & Pharma

So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…

Can the USA’s Fragmented Healthcare System Become More…

US healthcare is often seen as a fragmented system of contrasts. The country has the highest healthcare expenditures as a percentage of GDP and the…

Tagged with R